Biotech company Cybin has filed an international patent application related to methods for the delivery of psychedelic medications.
Meet Delic, a psychedelic and wellness event and expo for newcomers and veterans in the psychedelics space will take place in AREA15 in Las Vegas, this...
Currently, there is no cure for Parkinson’s Disease, however, certain medications can help improve symtoms.
Real-time quantification of brain activity during the psychedelic experience has been a major barrier within psychedelic research.
Sports luminaries including Mike Tyson will be among the world-leading speakers headlining the largest psychedelic medicine business conference next month.
Seattle council has unanimously voted to pass a resolution to decriminalise entheogenic substances.
Levitee Labs has announced it has listed on the Frankfurt Stock Exchange (FSE).
A free, virtual event is to explore the use of psychedelics for alcohol use disorder and binge drinking.
Results from a recent study have demonstrated a significant reduction in depressive symptoms and suicidality using ketamine as a solo treatment.
Data from Lobe Sciences has demonstrated that combination therapy of psilocybin and N-Acetylcysteine is more effective than monotherapy for mTBI and PTSD.
Better Life Pharma has obtained its first set of data on its lead compound TD-0148A, a second-generation LSD derivative, with further preclinical studies underway to determine...
Delix Therapeutics has raised $70m in a Series A funding round which is expected to fund its drug discovery platform of novel neuroplasticity-promoting compounds known as...